» Articles » PMID: 9630555

Sciatic Nerve Transection Evokes Lasting Up-regulation of Angiotensin AT2 and AT1 Receptor MRNA in Adult Rat Dorsal Root Ganglia and Sciatic Nerves

Overview
Date 1998 Jun 19
PMID 9630555
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

The angiotensin AT2 receptor is involved in tissue repair and cellular stress responses in non-neuronal cells. We have previously observed that the AT2 receptor-induced neurite formation in PC12W cells is paralleled by a reduced neurofilament M expression as it occurs in nerve fiber regeneration. Here we show that transection and crush of sciatic nerve fibers of adult rats results in dramatic changes of AT2, AT1a and AT1b receptor mRNA in dorsal root ganglion neurons (DRGs) and in sciatic nerves 3, 14 and 28 days after axotomy and crush. The expression patterns were determined by reverse transcription polymerase chain reaction (RT-PCR) assay, and the specificity of amplification products was verified by Southern blot hybridization. Whereas axotomy evoked a transient increase of AT2 receptor mRNA by more than 1000% after 3 days in proximal and after 14 days in distal sciatic nerve stumps (510%), the maximum expression in DRGs was observed after 14 days (1100%). Sciatic nerve crush resulted in a time-dependent up-regulation of AT2 receptor mRNA in sciatic nerve segments coinciding with the successful regeneration of nerve fibers. In sciatic nerves, AT1a and AT1b receptor mRNA levels were increased within different time-courses and to different extents with a maximum expression of 570%. In contrast to AT1a receptor mRNAs, AT1b receptor mRNA levels were increased in DRGs by maximally 800%. These results suggest that AT2 and AT1 receptor-mediated pathways are involved in Schwann cell-mediated myelination and in neuroregenerative responses of DRGs.

Citing Articles

Therapeutic opportunities in targeting the protective arm of the renin-angiotensin system to improve insulin sensitivity: a mechanistic review.

Dominici F, Gironacci M, Narvaez Pardo J Hypertens Res. 2024; 47(12):3397-3408.

PMID: 39363004 DOI: 10.1038/s41440-024-01909-y.


The Angiotensin AT Receptor: From a Binding Site to a Novel Therapeutic Target.

Steckelings U, Widdop R, Sturrock E, Lubbe L, Hussain T, Kaschina E Pharmacol Rev. 2022; 74(4):1051-1135.

PMID: 36180112 PMC: 9553111. DOI: 10.1124/pharmrev.120.000281.


Shedding Light on the Pharmacological Interactions between μ-Opioid Analgesics and Angiotensin Receptor Modulators: A New Option for Treating Chronic Pain.

Kiraly K, Karadi D, Zador F, Mohammadzadeh A, Galambos A, Balogh M Molecules. 2021; 26(20).

PMID: 34684749 PMC: 8537077. DOI: 10.3390/molecules26206168.


Ramipril Alleviates Oxaliplatin-Induced Acute Pain Syndrome in Mice.

Bouchenaki H, Danigo A, Bernard A, Bessaguet F, Richard L, Sturtz F Front Pharmacol. 2021; 12:712442.

PMID: 34349658 PMC: 8326755. DOI: 10.3389/fphar.2021.712442.


The Tissue Renin-Angiotensin System and Its Role in the Pathogenesis of Major Human Diseases: Quo Vadis?.

Saravi B, Li Z, Lang C, Schmid B, Lang F, Grad S Cells. 2021; 10(3).

PMID: 33804069 PMC: 7999456. DOI: 10.3390/cells10030650.